Healthcare / BiotechnologyUpdated 2026-05-10 22:07 UTC

NERV stock hub

Minerva Neurosciences, Inc. has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

NERVis not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

257.8M

NASDAQ

Market data

Live price

Current market quote for this ticker.

Current price

NERV

In the news

Latest news · NERV

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a

P25 12.3P50 18.4P75 33.1

Trailing P/En/a

P25 14.9P50 23.2P75 38.5

ROEn/a

P25 -105.6P50 -46.5P75 -3.1

ROICn/a

P25 -63.1P50 -27.3P75 0.5

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All NERV market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

173

Groups with data

Currency

USD

Showing 173 of 173 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Cik	0001598646
Company name	Minerva Neurosciences, Inc.
Country	United States
Country code	US
Cusip	603380205
Employees	7
Employees Change	-1%
Employees Change Percent	-12.5
Enterprise value	$239.7M
Exchange	NASDAQ
Financial currency	USD
First seen	2026-05-09
Industry	Biotechnology
IPO Date	2014-07-01
Isin	US6033802058
Last refreshed	2026-05-10
Market cap	$257.8M
Market cap category	Micro-Cap
Price	$5.92
Price currency	USD
Sector	Healthcare
Sic	2834
Symbol	NERV
Website	https://www.minervaneurosciences.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	-161.01%
FCF yield	-5.77%

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
Gross Profit	$-5.8M
Net Income	$-415.1M
Net Income Growth Years	0%
Profit Per Employee	$-59.3M
ROA	-27.47
Roa5y	-24.13
ROCE	-31.13

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr10y	-19.67%
Cagr1y	270.02%
Cagr3y	-0.47%
Cagr5y	-20.03%
EPS Growth Years	0
Revenue Growth Years	0x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Assets	$94M
Cash	$78.1M
Current Assets	$79.1M
Current Liabilities	$4.5M
Debt	$60M
Equity	$-249.1M
Liabilities	$343.1M
Long Term Assets	$14.9M
Long Term Liabilities	$338.6M
Net Cash	$18.1M
Net Cash By Market Cap	$7.01
Tangible Book Value	$-268.9M
Tangible Book Value Per Share	$-6.13
WACC	3

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	17.65
Net Working Capital	$-3.4M
Quick ratio	17.42
Working Capital	$74.6M

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-131.67%
Dividend Yield	0%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
10Y total return	-88.81%
1Y total return	269.69%
200-day SMA	4.28
3Y total return	-1.42%
50-day SMA	6.53
50-day SMA vs 200-day SMA	50over200
5Y total return	-67.28%
All Time High	126.7
All Time High Change	-95.33%
All Time High Date	2016-06-02
All Time Low	1.15
All Time Low Change	414.35%
All Time Low Date	2025-04-09
ATR	0.47
Beta	-0.1
Beta1y	1.22
Beta2y	1.3
Ch YTD	47.14
High	6.1
High52	12.46
High52 Date	2025-10-21
High52ch	-52.53%
Low	5.86
Low52	1.3
Low52 Date	2025-05-20
Low52ch	355%
Ma50ch	-9.35%
Price vs 200-day SMA	38.27%
RSI	42.22
RSI Monthly	56.74
RSI Weekly	54.71
Sharpe ratio	1.31x
Sortino ratio	4.21
Total Return	-131.67%
Tr YTD	47.14
Tr1m	14.19%
Tr1w	-2.55%
Tr3m	23.23%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Analyst Count	2
Analyst Count Top	1
Analyst Price Target Top	$7
Analyst Ratings	Buy
Analyst Ratings Top	Hold
Earnings EPS Estimate	$-0.13
Operating Income	$-27.9M
Price target	$10.5
Price Target Change	$77.52
Price Target Change Top	$18.34

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	25,183,460%
Float Percent	57.44%
Shares Insiders	0.64%
Shares Institutions	28.42%
Shares Out	43,841,998
Shares Qo Q	294.86%
Shares Yo Y	131.67%
Short Float	4.59%
Short Ratio	2.88
Short Shares	2.64

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	$-24.6M
Average Volume	149,956.65x
Bv Per Share	-5.79
Ch10y	-88.81
Ch1m	14.19
Ch1w	-2.55
Ch1y	269.7
Ch3m	23.23
Ch3y	-1.42
Ch5y	-67.28
Ch6m	59.43
Change	-3.51%
Change From Open	-3.03
Close	6.13
Days Gap	-0.49
Depreciation Amortization	5,442
Dollar Volume	441,726.3
Earnings Date	2026-05-05
Earnings Time	bmo
EBIT	$-27.9M
EBITDA	$-27.9M
EPS	$-23.66
F Score	2
FCF	$-14.9M
FCF EV Yield	-6.2x
FCF Per Share	$-0.34
Financing CF	75,529,866
Fiscal Year End	December
Founded	2,007
Goodwill	14,869,399
Investing CF	-45,294,104
Is Primary Listing	1
Is Spac	No
Last Earnings Date	2026-05-05
Last Report Date	2026-03-31
Last Split Date	2022-06-21
Last Split Type	Reverse
Last10k Filing Date	2026-03-11
Ma150	5
Ma150ch	18.37%
Ma20	6.4
Ma20ch	-7.58%
Net CF	15,369,722
Next Earnings Date	2026-08-13
Open	6.1
Optionable	No
Position In Range	22.92
Post Close	5.92
Postmarket Change Percent	-0.59
Postmarket Price	$5.88
Price Date	2026-05-08
Relative Volume	0.5x
Share Based Comp	9,740,445
Tr6m	59.43%
Us State	Massachusetts
Volume	74,679

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

Does NERV pay a dividend?

Capital-return profile for this ticker.

Performance

NERV stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns NERV?

Insider, institutional, and short-interest positioning.

Institutional ownership

+28.4%

Float: +57.4% of shares outstanding

Insider ownership

+0.6%

Stake held by company insiders. Higher generally signals alignment.

Negative means the company is buying back shares.

Technical

NERV momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

42.2

Neutral momentum band

Price vs 200-day MA

+38.3%

50/200-day relationship not available

Beta (5Y)

-0.10

Less volatile than the market

Sharpe ratio

1.31

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About NERV

Hub-level FAQ points readers to the deeper analysis pages.

What is the current NERV stock rating?

Minerva Neurosciences, Inc. is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full NERV analysis?

The full report lives at /stocks/NERV/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for NERV?

The latest report frames NERV around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the NERV page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.